Morrisons has opened its own £129-a-month fat jab club, which has left some shoppers unimpressed.
The chain says tirzepatide injections, sold under the brand name Mounjaro, can help users shed up to 20 per cent of their body weight.
But this has led to some shoppers pointing out what they perceive as the chain’s hypocrisy in selling fatty and sugary food and then in turn charging customers triple figures to help them lose weight, The Sun reports.
One shopper said: ‘This seems so unethical’ whilst another added: ‘You can buy your fatty and sugary foods and then a magic jab to make the results go away.’
Another called the idea ‘genius’, saying: ‘The store sells you unhealthy grub that gets you fat, then wants vast sums of money to get you thin.’
Another added: ‘How funny! Stuff your face with a six-pack of doughnuts, a multipack of Walkers crisps, a few sausage rolls followed by a tub of Ben & Jerry’s – and then for the privilege of parting with £129 you might lose weight! Oh my days.’
On its clinic website, the chain says the self-injectable pen design can be used once a week and to be used consistently.

The chain says tirzepatide injections, sold under the brand name Mounjaro, can help users shed up to 20 per cent of their body weight. Picture: stock image

But this has led to some shoppers pointing out what they perceive as the chain’s hypocrisy in selling fatty and sugary food and then in turn charging customers triple figures to help them lose weight
Morrisons Clinic: ‘Our approach to weight-loss treatments is based on three core factors, designed with your long-term health as our priority.
‘Our expert prescribing pharmacists are specially trained to review, consult and provide medications online. Your healthcare journey is in safe hands.
‘Our services are delivered by a team of dedicated pharmacists, prescribers and clinicians.’
Morrisons Clinic says the sign-up fee will rise to £159-a-month after the offer period.
It comes as previously reported that the UK medicines regulator has launched a probe into the safety of fat jabs after hundreds of Britons developed pancreatitis, leaving ten dead.
Officials are examining whether those affected have a genetic trait that leaves them at greater risk of side-effects from the likes of Mounjaro, Wegovy and Ozempic.
The Medicines and Healthcare products Regulatory Agency (MHRA) said it has received more than 560 reports of people developing an inflamed pancreas after taking so-called ‘GLP-1′ injections since they were first launched. Ten cases proved fatal.

Officials are examining whether those affected have a genetic trait that leaves them at greater risk of side-effects from the likes of Mounjaro, Wegovy and Ozempic
These drugs are typically known as ‘fat jabs’ or ‘skinny jabs’ as they are frequently used for weight management, but some are primarily licensed for the treatment of type 2 diabetes.
The MHRA is now calling for users who are admitted to hospital with pancreatitis to report the side effect to authorities using the regulator’s Yellow Card scheme.
Healthcare workers can also submit a report on patients’ behalf.
When a Yellow Card report is received, the MHRA will contact patients to ask if they would be willing to take part in the new Biobank study, in collaboration with Genomics England.
This would involve providing further information and submitting a saliva sample which will be used to explore whether some people are at a higher risk of acute pancreatitis when taking these medicines due to their genetic makeup.